- Home
- UUUU vs LNTH Comparison
UUUU vs LNTH Comparison
Compare UUUU & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUUU
- LNTH
- Stock Information
- Founded
- UUUU 1987
- LNTH 1956
- Country
- UUUU United States
- LNTH United States
- Employees
- UUUU N/A
- LNTH N/A
- Industry
- UUUU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- UUUU Industrials
- LNTH Health Care
- Exchange
- UUUU Nasdaq
- LNTH Nasdaq
- Market Cap
- UUUU 3.6B
- LNTH 3.8B
- IPO Year
- UUUU N/A
- LNTH 2015
- Fundamental
- Price
- UUUU $20.51
- LNTH $57.69
- Analyst Decision
- UUUU Strong Buy
- LNTH Buy
- Analyst Count
- UUUU 5
- LNTH 6
- Target Price
- UUUU $14.95
- LNTH $74.50
- AVG Volume (30 Days)
- UUUU 34.6M
- LNTH 1.4M
- Earning Date
- UUUU 11-03-2025
- LNTH 11-06-2025
- Dividend Yield
- UUUU N/A
- LNTH N/A
- EPS Growth
- UUUU N/A
- LNTH N/A
- EPS
- UUUU N/A
- LNTH 3.77
- Revenue
- UUUU $65,078,999.00
- LNTH $1,520,653,000.00
- Revenue This Year
- UUUU N/A
- LNTH N/A
- Revenue Next Year
- UUUU $105.42
- LNTH $2.25
- P/E Ratio
- UUUU N/A
- LNTH $15.29
- Revenue Growth
- UUUU 42.73
- LNTH 5.75
- 52 Week Low
- UUUU $3.20
- LNTH $47.25
- 52 Week High
- UUUU $27.33
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- UUUU 53.05
- LNTH 57.91
- Support Level
- UUUU $19.15
- LNTH $56.03
- Resistance Level
- UUUU $23.41
- LNTH $58.30
- Average True Range (ATR)
- UUUU 2.97
- LNTH 1.73
- MACD
- UUUU -0.44
- LNTH 0.17
- Stochastic Oscillator
- UUUU 28.59
- LNTH 86.00
About UUUU Energy Fuels Inc (Canada)
Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.